{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-120267","form_type":"8-K","ticker":"VKTX","cik":"0001607678","company_name":"Viking Therapeutics, Inc.","filed_at":"2024-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.955233+00:00","generated_at":"2026-05-30T06:06:19.695194+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"VK2735 oral Phase 1 shows up to 8.2% weight loss; Phase 2 data support monthly maintenance dosing","bullets":["Oral VK2735 achieved up to 8.2% mean weight loss from baseline (6.8% placebo-adjusted) at 28 days.","100% of subjects on 100 mg oral VK2735 reached ≥5% weight loss vs. 0% placebo; GI events mostly mild.","Phase 2 VENTURE: 94% of weight loss maintained 4 weeks post-final dose; supports once-monthly dosing.","78% of prediabetic patients on VK2735 shifted to normoglycemic over 13 weeks vs. 29% on placebo.","Oral Phase 2 to start by year-end 2024; injectable Phase 3 design to be discussed with FDA this quarter."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-120267","json":"https://secwatch.observer/filing/0000950170-24-120267.json","markdown":"https://secwatch.observer/filing/0000950170-24-120267.md","text":"https://secwatch.observer/filing/0000950170-24-120267.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024120267/0000950170-24-120267-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1607678/000095017024120267/vktx-20241104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T06:06:19.695194+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}